CLINICAL_TRIALS
trial_result
· 2012-10-01
Clinical Trial Update: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris [Phase 2]
Summary
Phase 2 trial of BLI1100 for moderate to severe acne vulgaris has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Braintree Laboratories | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED